HomeSOLARA › Filing
🔔 Get instant alerts when SOLARA files quarterly results on BSE Start free trial →

Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizer''s report of the Ninth Annual General Meeting

Filed: 22 Sep 2026, 17:54 IST Exchange: BSE Category: General Update — AGM Voting Results
Ninth Annual General Meeting held on September 18, 2026 via video conferencing. - All resolutions passed with requisite majority through remote e-voting and e-voting at meeting. - Adoption of audited standalone and consolidated financial statements for FY ended March 31, 2026 approved. - Appointment of Mr. Arun Kumar Pillai as Non-Executive Director approved. - Ratification of remuneration payable to Cost Auditor for FY 2026-27 approved. - Approval for material related party transactions with Strides Pharma Science Limited up to Rs.480 crores approved.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SOLARA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SOLARA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Solara Active Pharma Sciences Limited

Important. The summary above is generated automatically from Solara Active Pharma Sciences Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.